Search results
In the wake of Moderna, Inc.'s (NASDAQ:MRNA) latest US$2.7b market cap drop, institutional owners...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Institutions' substantial holdings in Moderna implies that they have significant...
Insider Sell: Chief Legal Officer Shannon Klinger Sells 557 Shares of Moderna Inc
GuruFocus.com via Yahoo Finance· 8 months agoOn September 8, 2023, Shannon Klinger, Chief Legal Officer of Moderna Inc (NASDAQ:MRNA), sold 557...
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough...
Business Insider via Yahoo News· 1 year agoStéphane Bancel, the CEO of Moderna.Nancy Lane/MediaNews Group/Boston Herald Moderna's cancer...
Moderna's betting big on personalized vaccines to treat cancer. Its CEO lays out his vision for how...
Business Insider via Yahoo News· 1 year agoModerna CEO Stéphane Bancel wants the COVID-19 vaccine developer to bring its mRNA technology to...
Moderna sues Pfizer after saying it wouldn't enforce its patents for COVID-19 vaccine technology
Business Insider via Yahoo News· 2 years agoA doctor vaccinates a student with the Moderna COVID-19 vaccine.Markus Schreiber/AP Photo Moderna is...
Institutional owners may consider drastic measures as Moderna, Inc.'s (NASDAQ:MRNA) recent US$6.3b...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
Business Insider via Yahoo Finance· 2 years agoModerna offices in Cambridge, Massachusetts.David L. Ryan/The Boston Globe via Getty Images Moderna...
Moderna slips after the COVID vaccine maker cuts 2022 sales guidance and misses 3rd quarter...
Business Insider via Yahoo Finance· 2 years agoAdministering Moderna's Covid-19 vaccine in London.Dinendra Haria/SOPA Images/LightRocket via Getty...
Investing in Moderna (NASDAQ:MRNA) five years ago would have delivered you a 367% gain
Simply Wall St. via Yahoo Finance· 1 month agoFor many, the main point of investing in the stock market is to achieve spectacular returns. While...
Institutional investors may adopt severe steps after Moderna, Inc.'s (NASDAQ:MRNA) latest 3.7% drop...
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Given the large stake in the stock by institutions, Moderna's stock price might be...